Multiple evanescent white dot syndrome, or MEWDs, was first described by Jampol and colleagues in 1984. It is categorised as a white dot syndrome (WDS), a group of inflammatory chorioretinopathies which clinically present as numerous, discrete white lesions affecting multiple layers of the retina including the retinal pigment epithelium (RPE), choroid and choriocapillaris. Other white dot syndromes include acute retinal pigment epitheliopathy (ARPE), acute posterior multifocal placoid pigment epitheliopathy (APMPPE), multifocal choroiditis and panuveitis (MCP) acute zonal occult outer retinopathy (AZOOR), punctate inner choroidopathy (PIC), serpiginous choroidopathy and birdshot chorioretinopathy. MEWDs is a unilateral condition which typically presents in women aged 20-50 years with a viral prodrome and has a benign and self-limiting course. The white dot syndromes are a rare entity with one multi-centre study calculating the incidence of WDS as 0.45 cases per 100,000, whilst other studies have reported the incidence of MEWDs as 0.22 per 100,000 population annually. We will provide an overview of this rare condition characterising its clinical presentation, clinical course and findings on ophthalmic imaging.

Bosch-Boonstra-Schaaf Optic Atrophy Syndrome (BBSOAS) is a rare genetic disorder resulting from mutations in the NR2F1 gene, known for its role in brain and ocular development. The syndrome, initially described by Bosch, Boonstra, and Schaaf, presents a spectrum of symptoms, with significant ophthalmologic involvement being central to its clinical picture. Visual impairment is often among the first indicators and a major contributor to the overall impact of the condition on affected individuals.

Comorbidity among ophthalmology patients is under recognised. Patients often need to see multiple sub-specialists for multiple conditions, and this can be overwhelming and often leads to appointments being missed. This is because currently there is a mismatch between the capacity and demand that current NHS Ophthalmology departments can offer. It was reported that 630,000 patients were waiting for an ophthalmology appointment in 2023 in comparison to 260,000 in 2011.

In medical school, I wasn’t always sure which path I wanted to pursue. Surgery seemed like a natural choice, especially given my family’s influence—my uncles and grandfather were all surgeons, specialising in general, paediatric, and orthopaedic surgery. They had built meaningful careers, and I felt the weight of their legacy as I considered my future. Nevertheless, nothing quite resonated with me, and for a while, I felt adrift, unsure of where I truly belonged. I always wanted to be different, envisioning a path that was uniquely my own.

Canaliculitis is an uncommon condition caused by chronic infection of the lacrimal canaliculus, a key part of the lacrimal drainage system. It is typically a unilateral condition and is associated with a variety of signs including discharge, epiphora, swelling of the eyelid and punctum pouting. Primary lacrimal canaliculitis (PLC) occurs mainly secondary to infection, most commonly due to actinomyces, staphylococcus, and streptococcus. Secondary canaliculitis, on the other hand, occurs as a complication of inter-canalicular or punctal plug insertion for the treatment of dry eye. Management can be conservative, with warm compress, topical and systemic antibiotics, irrigation, and syringing, or surgical, including punctoplasty, canaliculotomy, canalicular curettage, and silicone tube intubation.

Ocular Toxoplasmosis (OT), caused by the parasite Toxoplasma gondii, is considered the most common cause of infectious posterior uveitis. The infection can affect both congenital and postnatally infected individuals. Understanding the pathophysiology, clinical presentation, diagnosis, and management of this condition is essential as it can lead to severe visual impairment if left untreated.

A minimally invasive cosmetic treatment also known as a non-surgical procedure (NSP) refers to a procedure which involves small incisions or skin punctures intended to produce an aesthetic change with ‘minimal risk and downtime’. Dermal filler is used in multiple NSP, for example in the glabella region to “treat” deep-frown lines, in non-surgical rhinoplasty, in the tear-trough region to reduce hollowness of the tear trough and reduce under-eye circles and in the forehead for brow lifts. NSP in these areas have associated complications related to the eye including blindness and optic neuropathy.

Postoperative visual loss (POVL) is a rare complication of surgery. The spectrum of disability from POVL can range between transient blurring of vision, to permanent visual loss. Permanent POVL are most commonly attributed to central retinal artery occlusion, ischemic optic neuropathy, and cerebral vision loss, whilst other postoperative ocular injury can include corneal abrasion, which may or may not be associated with visual loss. The underlying mechanisms of POVL (postoperative visual loss) are not always fully understood, but it can arise from damage at any point along the visual pathway, from the cornea to the occipital lobe. The incidence for temporary POVL and permanent POVL of non-ocular procedures are 5.4 per 10,000 and 0.16 per 10,000 respectively, with the most prevalent cases occurring post cardiac surgery and spinal fusion.

Asteroid hyalosis (AH) is a benign vitreous opacification in which calcium-lipid complexes are suspended throughout the collagen fibrils inside the vitreous cavity. These complexes are named asteroid bodies due to their reflective appearance that resemble the stars (asteroids) in the night sky.